Allergan Announces Proposed Public Offering of Senior Notes to Refinance Existing Debt | 238.51 (-1.42%) AGN Announces Tender Offers by Certain Subsidiaries
AGN Q3 2017 earnings http://alph.st/b68181eb Regarding the Federal District Court's decision on Restasis, CEO Saunders said, "We have strong arguments for an appeal and we filed a notice of appeal with the Court. If a generic product enters the market, Allergan is ready to mitigate that impact by growing our base business, reducing costs and deploying our balance sheet."